Myung Shin

Myung Shin currently serves as the Vice President and Head of Early Discovery Translation & In Vitro Pharmacology at Kallyope since September 2022. Previously, Myung held the position of Vice President of Discovery at Ceptur Therapeutics from November 2021 to 2022 and dedicated over 17 years to Merck, where significant roles included Executive Director of Early Discovery Genetics and other leadership positions in genetics and pharmacogenomics. Myung's earlier experience includes an Associate Membership at Fox Chase Cancer Center and a Postdoctoral Fellowship at Princeton University. Myung holds a Bachelor of Arts in Biochemistry and Molecular Biology from Northwestern University and a Doctor of Philosophy in Molecular Biology from the University of California, Berkeley.